105 related articles for article (PubMed ID: 2543895)
41. Low dose of transdermal estradiol gel for treatment of symptomatic postmenopausal women: a randomized controlled trial.
Simon JA; Bouchard C; Waldbaum A; Utian W; Zborowski J; Snabes MC
Obstet Gynecol; 2007 Mar; 109(3):588-96. PubMed ID: 17329509
[TBL] [Abstract][Full Text] [Related]
42. Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.
Henzl MR; Loomba PK
J Reprod Med; 2003 Jul; 48(7):525-40. PubMed ID: 12953327
[TBL] [Abstract][Full Text] [Related]
43. Comparative controlled trial of a novel oral estrogen therapy, estradiol acetate, for relief of menopause symptoms.
Utian WH; Speroff L; Ellman H; Dart C
Menopause; 2005; 12(6):708-15. PubMed ID: 16278614
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and tolerability of Menorest 50 compared with Estraderm TTS 50 in the treatment of postmenopausal symptoms. A randomized, multicenter, parallel group study.
Pornel B; Genazzani AR; Costes D; Dain MP; Lelann L; Vandepol C
Maturitas; 1995 Nov; 22(3):207-18. PubMed ID: 8746878
[TBL] [Abstract][Full Text] [Related]
45. [One-year follow-up of women treated with transdermal administration of estrogen for post-castration and climacteric syndromes].
Rotta L; Matĕchová E
Cesk Gynekol; 1992 Dec; 57(9-10):479-88. PubMed ID: 1291124
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and tolerability of Estraderm MX, a new estradiol matrix patch.
Bacchi-Modena A; Bolis P; Campagnoli C; De Cicco F; Meschia M; Pansini F; Pisati R; Hüls G
Maturitas; 1997 Jul; 27(3):285-92. PubMed ID: 9288701
[TBL] [Abstract][Full Text] [Related]
47. HRT and long-term compliance: the efficacy and safety of Menorest.
Studd J; Panay N; Zamblera D; Leather AT
Int J Gynaecol Obstet; 1996 Mar; 52 Suppl 1():S21-5. PubMed ID: 8666123
[TBL] [Abstract][Full Text] [Related]
48. [A transdermal therapeutic system for hormonal therapy of climacteric deficiency pictures. A multicenter study].
Kerzel C; Keller PJ
Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):565-8. PubMed ID: 3653671
[TBL] [Abstract][Full Text] [Related]
49. A risk-benefit appraisal of transdermal estradiol therapy.
Cheang A; Sitruk-Ware R; Utian WH
Drug Saf; 1993 Nov; 9(5):365-79. PubMed ID: 8280404
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.
Powers MS; Schenkel L; Darley PE; Good WR; Balestra JC; Place VA
Am J Obstet Gynecol; 1985 Aug; 152(8):1099-106. PubMed ID: 2992279
[TBL] [Abstract][Full Text] [Related]
51. A comparison of oestrogen-progestogen with clonidine in the climacteric syndrome.
Sonnendecker EW; Polakow ES
S Afr Med J; 1980 Nov; 58(19):753-6. PubMed ID: 6252641
[TBL] [Abstract][Full Text] [Related]
52. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). I. Tolerability, adhesion and efficacy.
Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J
Maturitas; 1996 Nov; 25(3):161-73. PubMed ID: 8981333
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of Menorest in two positive-controlled studies.
Pornel B
Eur J Obstet Gynecol Reprod Biol; 1996 Apr; 64 Suppl():S35-7. PubMed ID: 8732472
[TBL] [Abstract][Full Text] [Related]
54. Randomized comparison of intranasal and transdermal estradiol.
Lopes P; Merkus HM; Nauman J; Bruschi F; Foidart JM; Calaf J
Obstet Gynecol; 2000 Dec; 96(6):906-12. PubMed ID: 11084176
[TBL] [Abstract][Full Text] [Related]
55. Comparison of two estradiol transdermal systems (Oesclim 50 and Estraderm TTS 50). II. Local skin tolerability.
Rozenbaum H; Birkhäuser M; De Nooyer C; Lambotte R; Pornel B; Schneider H; Studd J; Thebault J
Maturitas; 1996 Nov; 25(3):175-85. PubMed ID: 8981334
[TBL] [Abstract][Full Text] [Related]
56. [Comparison of the osteoprotective effects of orally administered equine conjugated estrogens and percutaneous 17 beta-estradiol].
Reginster JY; Sarlet N; Deroisy R; Denis D; Lecart MP; Franchimont P
Rev Med Liege; 1989 Jan; 44(2):55-60. PubMed ID: 2538905
[No Abstract] [Full Text] [Related]
57. The climacteric syndrome: an estrogen replacement dilemma.
Strickler RC; Borth R; Woodlever CA
Can Med Assoc J; 1977 Mar; 116(6):586-7. PubMed ID: 204404
[No Abstract] [Full Text] [Related]
58. [Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric].
Lumholtz IB
Sygeplejersken; 1979 Sep; 79(38):10. PubMed ID: 229580
[No Abstract] [Full Text] [Related]
59. The psychotropic properties of estrogens.
Herrmann WM; Beach RC
Pharmakopsychiatr Neuropsychopharmakol; 1978 Jul; 11(4):164-76. PubMed ID: 209485
[TBL] [Abstract][Full Text] [Related]
60. [Effect of natural estrogens and diazepam alone and in combination on the climacteric syndrome].
Horský J
MMW Munch Med Wochenschr; 1979 Jun; 121(22):765-6. PubMed ID: 224313
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
